- Director Henderson Michael Thomas sold $2,000,000 worth of shares (20,000 units at $100.00) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 68,606 units (SEC Form 4)
4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
- President, CEO & Chairman Selwyn Joffe converted options into 66,432 shares, increasing direct ownership by 12% to 630,535 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- VP, Gen Counsel and Secretary Stone Juliet Lynn converted options into 5,442 shares, increasing direct ownership by 16% to 38,838 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- New insider Ajello James A claimed ownership of 52,244 shares (SEC Form 3)
3 - HAWAIIAN ELECTRIC INDUSTRIES INC (0000354707) (Issuer)
- VP, General Counsel & Sec. Burlingame Glenn Daniel converted options into 5,176 shares, increasing direct ownership by 340% to 6,700 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.76% to 276,420 units (SEC Form 4) to satisfy tax liability
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Chief Manufacturing Officer Schooner Douglas Earl converted options into 6,758 shares, increasing direct ownership by 19% to 42,465 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- Chief Accounting Officer Humes Jennifer covered exercise/tax liability with 3,582 shares, decreasing direct ownership by 3% to 109,782 units (SEC Form 4) (for withholding tax)
4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Director Orsel Karin Y
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- Director Das Paramita converted options into 9,554 shares (SEC Form 4)
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- SEC Form 4 filed by Director Regan Arthur L
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- SEC Form 4 filed by Director Haines Kathleen C
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- SEC Form 4 filed by Director Mavroleon Basil G
4 - GENCO SHIPPING & TRADING LTD (0001326200) (Issuer)
- Chief Accounting Officer Shah Kamlesh converted options into 6,671 shares, increasing direct ownership by 19% to 42,373 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)
- Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced the expiration and final results of the previously announced offers to exchange (the "Exchange Offers") any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the "2029 Notes") and 6.625% Senior Notes due 2030 (the "2030 Notes" and, together with the 2029 Notes, the "Existing Notes"). As of 5:00 P.M., New York City time, on June 23, 2026 (the "Expiration Time"), the Company received from Eligible Holders valid and unwithdrawn tenders and related Consents (as defined below), as reported by Epiq Corporate Restructuring, LLC (the "Exchange Agent" and "Information Agent"), representing approximately $478.3 millio
- uniQure Announces Pricing of Upsized $225 Million Public Offering
LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its previously announced underwritten public offering of 4,945,055 ordinary shares at a public offering price of $45.50 per share. The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, are expected to be approximately $225 million. All securities to be sold in the offering are being sold by uniQure. In addition, uniQure has granted to the underwriters a 30-d
- CFO Lee David Sung converted options into 16,481 shares, increasing direct ownership by 24% to 84,019 units (SEC Form 4)
4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)